Broad Institute is empowering a revolution in biomedicine to accelerate the pace at which the world conquers disease
Propelling the understanding and treatment of disease
Collaborating deeply
Broad Institute is a mission-driven community that brings together researchers in medicine, biology, chemistry, computation, engineering, and mathematics from across MIT, Harvard, and Harvard-affiliated hospitals, along with collaborators around the world
Reaching globally
Broad Institute is committed to addressing medical challenges across the world, including collaborating with scientists and public health experts to address important needs in developing countries
Empowering scientists
Broad Institute fosters an environment in which scientists can take risks on bold ideas with transformative potential
Building partnerships
Broad Institute works to build and sustain international consortia to speed discovery in areas including psychiatric research, infectious disease, cardiovascular disease, and cancer
Promoting inclusion
Broad Institute believes that progress in biomedical research requires a fully inclusive community across sex, race, ethnicity, sexual orientation, age, and gender identity
INSIDE BROAD
News / 04.19.18
In defining the cellular context of diffuse midline gliomas, researchers find the cells fueling their growth and suggest a potential approach to treating them: forcing their cells to be more mature.Read more
News / 04.13.18
Compiled by Cancer Dependency Map group, tool lets researchers identify cancer vulnerabilities.Read more
News / 04.13.18
Prior to publishing, researchers compile and make raw data openly accessible on preview version of Data Coordination PlatformRead more
News / 04.11.18
Proteomic data can now help improve our understanding of how drugs respond in disease models.Read more
News / 04.5.18
The Cancer Genome Atlas Research Network’s systematic push to comprehensively analyze 33 forms of cancer marks the “end of the beginning” of cancer genomics.Read more
News / 04.2.18
By studying the largest collection yet of prostate cancer samples to be analyzed genomically, researchers have identified genes never before linked to prostate tumors, and started to see patterns that tell localized tumors from metastatic ones.Read more
Podcast / 03.27.18
John Doench, associate director of the Genetic Perturbation Platform (GPP) and institute scientist at the Broad Institute, and Ruth Hanna, research associate in GPP, discuss how the CRISPR system has revolutionized studies of gene function.Read more
News / 03.16.18
A rare genetic disorder reveals a surprising factor influencing whether red blood cells' ancestors develop normally or not at all: their abundance of ribosomes.Read more
Blog / 03.6.18
A global collaboration, NeuroGAP-Psychosis, aims to plumb the genetic diversity of psychiatric disease in Africa. Three of the collaboration's African site leaders discuss the opportunities and challenges they see, as well as why the right time for this study is now.Read more
Blog / 04.6.18
With new data from 23andMe and the UK Biobank, the GIANT Consortium is expanding opportunities to understand the genetics and biology of height and obesity.Read more
Blog / 04.16.18
In a #WhyIScience Q&A, the Meyerson Lab postdoc talks about her efforts to understand why cancer cells often have the wrong number of chromosomes, and shares what she’s learned as an emerging...Read more
Blog / 03.28.18
A microbial genomics expert talks about trends in her field, as well as her approach to mentorship and leadership, in a #WhyIScience Q&ARead more
Blog / 03.22.18
In a #WhyIScience Q&A, the director of the Broad’s Imaging Platform discusses her trailblazing work developing tools that analyze biological imagesRead more